Atezolizumab is an immune checkpoint inhibitor used in cancer immunotherapy. It targets the PD-L1 protein, which tumors use to evade the immune system, helping to restore the body's ability to fight cancer cells. It is used in the treatment of non-small cell lung cancer, urothelial carcinoma, and other cancers.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Atezolizumab and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Atezolizumab impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Atezolizumab-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
